Simmi Wiggins, n/a

PhD
Sanofi, Reading, UK, United Kingdom

Poster(s):

• (236) Dupilumab monotherapy vs topical corticosteroids in prurigo nodularis: impact on signs and symptoms in the PRIME/PRIME2 studies
  Wednesday, October 29, 2025